These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20737641)

  • 21. Determination of hepatic clearance with the account of drug-protein binding kinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2012 Oct; 101(10):3936-45. PubMed ID: 22767378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics.
    McNamara PJ; Slattery JT; Gibaldi M; Levy G
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):397-405. PubMed ID: 512845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
    Wan H; Rehngren M
    J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of drug plasma protein binding by solid phase microextraction.
    Musteata FM; Pawliszyn J; Qian MG; Wu JT; Miwa GT
    J Pharm Sci; 2006 Aug; 95(8):1712-22. PubMed ID: 16795010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of recovery on fraction unbound using equilibrium dialysis.
    Di L; Umland JP; Trapa PE; Maurer TS
    J Pharm Sci; 2012 Mar; 101(3):1327-35. PubMed ID: 22161810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
    Zhang F; Xue J; Shao J; Jia L
    Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of high-dosage naproxen in elderly patients.
    Van den Ouweland FA; Jansen PA; Tan Y; Van de Putte LB; Van Ginneken CA; Gribnau FW
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):143-7. PubMed ID: 3410597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microseparation techniques for the study of the enantioselectivity of drug-plasma protein binding.
    Escuder-Gilabert L; Martínez-Gómez MA; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ
    Biomed Chromatogr; 2009 Mar; 23(3):225-38. PubMed ID: 19016227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems II. Binding of different ligands to plasma proteins.
    Dawidowicz AL; Kobielski M; Pieniadz J
    Eur J Pharm Sci; 2008 Sep; 35(1-2):136-41. PubMed ID: 18644440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Lombardo F; Obach RS; Shalaeva MY; Gao F
    J Med Chem; 2004 Feb; 47(5):1242-50. PubMed ID: 14971904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of drug-protein interactions by capillary electrophoresis hyphenated to mass spectrometry.
    Vuignier K; Veuthey JL; Carrupt PA; Schappler J
    Electrophoresis; 2012 Nov; 33(22):3306-15. PubMed ID: 22949263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational use of plasma protein and tissue binding data in drug design.
    Liu X; Wright M; Hop CE
    J Med Chem; 2014 Oct; 57(20):8238-48. PubMed ID: 25099658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the distribution of drugs in saliva and blood plasma.
    Feller K; le Petit G
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):468-9. PubMed ID: 21854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein binding of drugs.
    Heald AF; Singhvi SM
    Ann Clin Lab Sci; 1978; 8(3):239-43. PubMed ID: 655609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-protein binding: a critical review of analytical tools.
    Vuignier K; Schappler J; Veuthey JL; Carrupt PA; Martel S
    Anal Bioanal Chem; 2010 Sep; 398(1):53-66. PubMed ID: 20454782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.